NCT01054781
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
Clinical trial condition
Diffuse Large B-Cell Lymphoma (DLBCL)
Explore clinical trials studying Diffuse Large B-Cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.
45 public trials
20 recruiting studies
Diffuse Large B-Cell Lymphoma (DLBCL) trial results
Active, Not Recruiting
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
NCT01829958
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
Active, Not Recruiting
Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
NCT05583149
- Conditions
- Aggressive B-cell NHL, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +27 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
Active, Not Recruiting
Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
NCT02570542
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up Only) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Consent and Follow up Only) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Consent and Follow Up Only) Montvale, New Jersey, United States
Active, Not Recruiting
ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)
NCT04049513
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Wellington Hospital, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley Wellington, New Zealand